DEFINITIVE PROXY STATEMENT - SENESCO TECHNOLOGIES

Company

Eloxx Pharmaceuticals, Inc.

Filed

October 28, 1999

Period of Report

November 30, 1999

Accession Number

0001015357-99-000118

A DEF 14A is a proxy statement sent to shareholders before an annual meeting. It covers executive compensation, board elections, and shareholder votes. Learn more about DEF 14A filings →